Biotechnology and genetic engineering in the new drug development. Part I. DNA technology and recombinant proteins.
Journal Title: Pharmacological Reports - Year 2013, Vol 65, Issue 5
Abstract
Pharmaceutical biotechnology has a long tradition and is rooted in the last century, first exemplified by penicillin and streptomycin as low molecular weight biosynthetic compounds. Today, pharmaceutical biotechnology still has its fundamentals in fermentation and bioprocessing, but the paradigmatic change affected by biotechnology and pharmaceutical sciences has led to an updated definition. The biotechnology revolution redrew the research, development, production and even marketing processes of drugs. Powerful new instruments and biotechnology related scientific disciplines (genomics, proteomics) make it possible to examine and exploit the behavior of proteins and molecules. Recombinant DNA (rDNA) technologies (genetic, protein, and metabolic engineering) allow the production of a wide range of peptides, proteins, and biochemicals from naturally nonproducing cells. This technology, now approximately 25 years old, is becoming one of the most important technologies developed in the 20(th) century. Pharmaceutical products and industrial enzymes were the first biotech products on the world market made by means of rDNA. Despite important advances regarding rDNA applications in mammalian cells, yeasts still represent attractive hosts for the production of heterologous proteins. In this review we describe these processes.
Authors and Affiliations
Agnieszka Stryjewska, Katarzyna Kiepura, Tadeusz Librowski, Stanisław Lochyński
Keywords
Related Articles
- EP ID EP110055
- DOI -
- Views 91
- Downloads 0
Bismuth increases hydroxyl radical-scavenging activity of histamine H(2)-receptor antagonists.
The effects of histamine H(2)-receptor antagonists, alone or in a combination with bismuth, on ( )OH-provoked degradation of deoxyribose were studied. The histamine H(2)-receptor antagonists (cimetidine, ranitidine and r...
Endogenous neuroprotective factors: neurosteroids.
Neurosteroids are a group of steroid hormones synthesized by the brain in the presence of steroidogenic enzymes. Specific neurosteroids modulate function of several receptors,and also regulate growth of neurons, myeliniz...
Glyburide for the treatment of gestational diabetes mellitus.
Insulin is the traditional treatment for gestational diabetes mellitus (GDM) unresponsive to dietary interventions. Until recently, oral hypoglycemic drugs had been contraindicated due to concerns regarding teratogenicit...
Tricaine (MS-222) is a safe anesthetic compound compared to benzocaine and pentobarbital to induce anesthesia in leopard frogs (Rana pipiens).
Tricaine (MS-222) is used commonly for sedation, immobilization, and anesthesia of poikilothermic animals. The anesthetic efficacy of different concentrations of MS-222 was compared to benzocaine and pentobarbital on the...
Influence of short-term L-arginine supplementation on carbohydrate balance in rats with ischemia-reperfusion syndrome.
Background: There are studies showing stimulative effect of arginine on insulin secretion. This mechanism is not fully explained. The effects of the impact of arginine on carbohydrate balance under the conditions of isch...